2015 speaker include

 Peadar Mac Gabhann
Peadar Mac Gabhann
Director
Biostór Ireland
 Arndt Schmitz
Arndt Schmitz
Head of Research Biobank
Bayer Pharma AG
 Marcel Bruinenberg
Marcel Bruinenberg
Project Manager
LifeLines
 Heli Salimen-Mankonen
Heli Salimen-Mankonen
Research Director
Auria Biobank
Sanofi
Anne Bahr
Privacy Officer
Sanofi
 Victoria Haggerson
Victoria Haggerson
Manager of Biological Sample Management
GlaxoSmithKline
 Chris Christodoulou
Chris Christodoulou
Head of Laboratory Compliance
MedImmune
 Anna Bosch-Comas
Anna Bosch-Comas
Facility Coordinator
IDIBAPS
 Francisco de Luna
Francisco de Luna
Deputy Coordinator of the National Biobank Network
CNIO

Ensure Biobank Growth with High Quality Samples, Effective Data Management, Knowledge Sharing and Compliance

Biobanks sit in the heart of R&D, serving as a biological sample library for researchers and clinicians. Now, biobanks are progressing forward towards automated biobanking to improve sample management and utilisation as well as becoming sample information warehouses through the implementation of advanced data management systems.

To meet sample demands, resources are being pulled and samples for large scale studies are being acquired from multiple biobanks. As a result, biobank interoperability is at the forefront of discussion with EU initiatives focusing on the harmonisation of quality standards and data.

The increased amount of sample and information sharing between both biobanks and research facilities has ignited major discussions on ethical policies including obtaining informed consent and maintaining patient privacy and confidentiality; in addition to handling country-specific legal and ethical requirement when distributing samples internationally.

The 7th annual Global Biobanking Summit will be bringing together Heads of biobank and sample management across both public and private sectors and experts in biobanking ethics to discuss challenges and share best practice to grow your biobank successfully.

The key topics of this year's event include: data privacy, country-specific legal and ethical requirements, quality management, quality standards and biobanking informatics. In addition, the pre-conference day focuses on strategies to achieve a sustainable biobank and facilitate partnerships between academia and industry.

Pharma IQ’s Global Biobanking Summit has a seven-year track record of expert international speakers, compelling discussions and long-term networking opportunities. The 2015 event will be bringing together top industry professionals returning with a more discussion based agenda providing you with that extra time to understand the challenges in depth and develop partnerships for future collaboration.

P.S. Take a look at our BRAND NEW focus day on biobank funding and sustainability

Key discussion points of 2015:

  • Understanding country-specific ethical and legal requirements
  • Handling informed consent, secondary use of samples and consent withdrawal
  • Setting quality standards to reduce sample variability
  • Data management with an advanced informatics system to meet biobank needs
  • Increasing sample utilisation from an effective sample management system
  • Facilitating collaboration between academia and industry

Sponsors & Exhibitors
Media Partners

Download 2015 Draft Agenda

Resource Centre

Visit the Resource Center for complimentary industry related content!

Featured Content

Sponsorship Opportunity

Learn more about sponsor & exhibit opportunities

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!

Quick Links